ArticleChemistry & biodiversity2026
A Simple and Rapid New Method for Thiolated DNA Modification of Copper Sulfide Nanoparticles: Preparation of Materials for Cancer Photothermal Therapy.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
We have demonstrated a rapid and efficient strategy for modifying copper sulfide nanoparticles (CuS NPs) with thiol-modified DNA (SH-DNA) under acidic conditions (CDLp) for the first time. The CDLp method involves mixing CuS NPs with an acidic-citrate buffer (pH = 3.0), rapidly adding SH-DNA, and incubating at 25°C for 10 min to obtain the CuS-DNA conjugate. In contrast, the traditional Salt-aging method requires 12 h to produce CuS-DNA. The experimental results show that the CuS-DNA obtained by the CDLp has similar stability and photothermal properties compared with the CuS-DNA synthesized by the Salt aging method, but it shortens the modification time by more than 10 h. This saves time and costs for the subsequent preparation of photothermal therapy platforms based on CuS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.